BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 35364753)

  • 1. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
    Wei C; Liu Y; Jiang A; Wu B
    Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis.
    Jiang A; Wei C; Zhu W; Wu F; Wu B
    Ther Adv Drug Saf; 2024; 15():20420986241244585. PubMed ID: 38715707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System.
    Wang H; Yang H; Zhou X; Zhang X
    Clin Ther; 2023 Feb; 45(2):151-159. PubMed ID: 36682994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor: A pharmacovigilance analysis of the FDA adverse event reporting system (FAERS).
    Shi A; Nguyen H; Kuo CB; Beringer PM
    J Cyst Fibros; 2024 May; 23(3):566-572. PubMed ID: 38233246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data.
    Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B
    Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022.
    Huang H; Li L; Wu M; Liu Z; Zhao Y; Peng J; Ren X; Chen S
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):73. PubMed ID: 38049920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system.
    Liu Y; Li H; Huang L; Wan C; Wang H; Jiao X; Zeng L; Jia Z; Cheng G; Zhang L; Zhang W; Zhang L
    BMC Pediatr; 2023 Sep; 23(1):492. PubMed ID: 37770847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding Complications in Vancomycin-Induced Thrombocytopenia: A Real-world Postmarketing Pharmacovigilance Analysis.
    Yang H; Zhang Y; Feng X; An Z
    Clin Ther; 2023 Sep; 45(9):868-872. PubMed ID: 37640615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database.
    Wu X; Zhang L; Huang H; Huang L; Lu X; Wang Z; Xiao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):422-434. PubMed ID: 37164926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
    Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
    Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic lymphoma kinase tyrosine kinase inhibitors associated gastrointestinal obstruction, perforation, and ulceration: an analysis of the FDA adverse event reporting system database (FAERS).
    Huang J; Zhao Y; Cao Y; Zhang Q; Ran D; Li J; Luo L; Qiu F; Meng L
    Int J Clin Pharm; 2022 Aug; 44(4):993-1003. PubMed ID: 35776375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database.
    Wei L; Tian Y; Chen X; Guo X; Chen C; Zheng Y; Xu J; Ye X
    Int J Clin Pharm; 2023 Jun; 45(3):622-629. PubMed ID: 36848023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
    Patek TM; Teng C; Kennedy KE; Alvarez CA; Frei CR
    Drug Saf; 2020 Jan; 43(1):17-22. PubMed ID: 31691256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of gynecomastia with antidiabetic medications in older adults: Data mining from different national pharmacovigilance databases.
    Ohyama K; Tanaka H; Shindo J; Shibayama M; Iwata M; Hori Y
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):24-31. PubMed ID: 34622771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.
    Zhuang W; Xu J; Wu Y; Yang J; Lin X; Liao Y; Wan J; Weng L; Lin W
    Br J Clin Pharmacol; 2023 Sep; 89(9):2830-2842. PubMed ID: 37170890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the association between Janus kinase inhibitors and malignant skin tumors using the Food and Drug Administration Adverse Event Reporting System.
    Liu T; Gao R; Li L; Wu B; Wu F
    Int J Clin Pharm; 2023 Dec; 45(6):1483-1491. PubMed ID: 37606843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.
    Chen JJ; Huo XC; Wang SX; Wang F; Zhao Q
    Int J Clin Pharm; 2022 Dec; 44(6):1351-1360. PubMed ID: 36178607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.